A randomised double-blind placebo-controlled study to investigate the possible role of Opiate Morphine (MST) in the treatment of chronic cough.
Completed
- Conditions
- Chronic coughRespiratoryCough
- Registration Number
- ISRCTN18474014
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
30 subjects from Hull Cough Clinic
Exclusion Criteria
Does not match inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie MST's antitussive effects in chronic cough via opioid receptor modulation?
How does MST compare to standard-of-care antitussives like dextromethorphan in chronic cough clinical trials?
Which biomarkers correlate with MST response in chronic cough patients with refractory symptoms?
What are the safety profiles of MST versus placebo for chronic cough in UK National Health Service trials?
Are there synergistic effects of MST with antihistamines or neuromodulators in chronic cough treatment strategies?